NanJing Pharmaceutical Co Ltd (600713) — Cash Flow-to-Debt Ratio
NanJing Pharmaceutical Co Ltd (600713) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-942.93 Million could theoretically repay 0% of its total liabilities (CN¥26.09 Billion) in one year. See financial agility of NanJing Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NanJing Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for NanJing Pharmaceutical Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see NanJing Pharmaceutical Co Ltd (600713) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for NanJing Pharmaceutical Co Ltd (1998–2024)
Year-by-year debt coverage analysis for NanJing Pharmaceutical Co Ltd. Check NanJing Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CN¥2.14 Billion | CN¥22.89 Billion | ▲ +3.6% |
| 2023 | 0.09x | CN¥1.91 Billion | CN¥21.16 Billion | ▲ +429.6% |
| 2022 | -0.03x | CN¥-682.31 Million | CN¥24.96 Billion | ▼ -181.2% |
| 2021 | 0.03x | CN¥695.33 Million | CN¥20.65 Billion | ▲ +154.3% |
| 2020 | -0.06x | CN¥-1.15 Billion | CN¥18.59 Billion | ▼ -207.7% |
| 2019 | 0.06x | CN¥1.00 Billion | CN¥17.45 Billion | ▲ +342.3% |
| 2018 | -0.02x | CN¥-366.90 Million | CN¥15.45 Billion | ▼ -194.6% |
| 2017 | 0.03x | CN¥319.99 Million | CN¥12.74 Billion | ▲ +213.6% |
| 2016 | -0.02x | CN¥-240.88 Million | CN¥10.89 Billion | ▲ +28.4% |
| 2015 | -0.03x | CN¥-306.08 Million | CN¥9.91 Billion | ▲ +19.1% |
| 2014 | -0.04x | CN¥-341.01 Million | CN¥8.92 Billion | ▲ +9.8% |
| 2013 | -0.04x | CN¥-354.27 Million | CN¥8.36 Billion | ▼ -299.4% |
| 2012 | 0.02x | CN¥168.17 Million | CN¥7.91 Billion | ▲ +123.5% |
| 2011 | -0.09x | CN¥-692.53 Million | CN¥7.67 Billion | ▼ -639.4% |
| 2010 | 0.02x | CN¥119.08 Million | CN¥7.11 Billion | ▲ +378.2% |
| 2009 | 0.00x | CN¥20.22 Million | CN¥5.77 Billion | ▲ +258.8% |
| 2008 | 0.00x | CN¥4.33 Million | CN¥4.43 Billion | ▼ -94.8% |
| 2007 | 0.02x | CN¥81.08 Million | CN¥4.30 Billion | ▼ -64.4% |
| 2006 | 0.05x | CN¥161.31 Million | CN¥3.04 Billion | ▼ -14.1% |
| 2005 | 0.06x | CN¥165.57 Million | CN¥2.68 Billion | ▲ +856.7% |
| 2004 | 0.01x | CN¥16.26 Million | CN¥2.52 Billion | ▼ -32.4% |
| 2003 | 0.01x | CN¥19.27 Million | CN¥2.02 Billion | ▼ -81.8% |
| 2002 | 0.05x | CN¥68.75 Million | CN¥1.31 Billion | ▲ +970.8% |
| 2001 | -0.01x | CN¥-4.20 Million | CN¥697.93 Million | ▼ -105.1% |
| 2000 | 0.12x | CN¥87.68 Million | CN¥742.31 Million | ▲ +17.1% |
| 1999 | 0.10x | CN¥50.58 Million | CN¥501.56 Million | ▼ -42.7% |
| 1998 | 0.18x | CN¥77.45 Million | CN¥440.31 Million | — |